Call Boomerang Books 1300 36 33 32

Description - Defining Optimal Immunotherapies for Type 1 Diabetes by Novartis Foundation

* This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).* Brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials.* The book integrates information from human and animal studies.* The book considers T1D within the broader context of autoimmune disease.* The format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure.

Buy Defining Optimal Immunotherapies for Type 1 Diabetes by Novartis Foundation from Australia's Online Independent Bookstore, Boomerang Books.

Book Details

ISBN: 9780470723258
ISBN-10: 0470723254
Format: Hardback
(236mm x 163mm x 16mm)
Pages: 222
Imprint: Wiley-Blackwell
Publisher: John Wiley and Sons Ltd
Publish Date: 13-Jun-2008
Country of Publication: United States

Book Reviews - Defining Optimal Immunotherapies for Type 1 Diabetes by Novartis Foundation

» Have you read this book? We'd like to know what you think about it - write a review about Defining Optimal Immunotherapies for Type 1 Diabetes book by Novartis Foundation and you'll earn 50c in Boomerang Bucks loyalty dollars (you must be a Boomerang Books Account Holder - it's free to sign up and there are great benefits!)

Write Review


Books By Novartis Foundation

Growth Factors and Psychiatric Disorders by Novartis Foundation
Hardback, February 2008
$284.36